Yes, hydrocodone is an opioid. Specifically, it is a semi-synthetic opioid, meaning it is derived from naturally occurring compounds found in the opium poppy but chemically modified in a lab. The FDA classifies it as both an analgesic (pain reliever) and an antitussive (cough suppressant), and the DEA lists it as a Schedule II controlled substance, the second-most restrictive category for prescription drugs.
What “Semi-Synthetic Opioid” Means
Opioids fall into three broad categories: natural opiates like morphine and codeine, which come directly from the poppy plant; semi-synthetic opioids like hydrocodone and oxycodone, which are chemically altered versions of those natural compounds; and fully synthetic opioids like fentanyl, which are built entirely in a lab. Hydrocodone sits in the middle category. It works on the same brain receptors as all other opioids, binding to sites in the central nervous system that reduce pain signals and can produce feelings of euphoria.
Your liver processes hydrocodone using a specific enzyme called CYP2D6, which converts part of the drug into hydromorphone, a more potent opioid. How effectively your body performs this conversion varies from person to person based on genetics, which is one reason the same dose can affect two people differently.
How Hydrocodone Is Prescribed
Hydrocodone is almost always prescribed as a combination product, paired with a non-opioid pain reliever or another active ingredient. The most common pairing is hydrocodone with acetaminophen (the active ingredient in Tylenol). You may recognize brand names like Vicodin, Norco, or Lortab, though most of these branded versions have been discontinued in favor of generics. Other formulations combine hydrocodone with ibuprofen (once sold as Vicoprofen) or with antihistamines for cough suppression (such as Tussionex).
In terms of strength, hydrocodone has a 1:1 conversion factor with oral morphine. That means 5 mg of hydrocodone is roughly equivalent to 5 mg of oral morphine, placing it in the moderate range of opioid potency.
Why It Was Reclassified as Schedule II
Until October 2014, hydrocodone combination products were classified as Schedule III, a less restrictive category that allowed easier prescribing, including phone-in refills. Pure hydrocodone had been Schedule II since the Controlled Substances Act was enacted in 1971, but combination products with non-opioid ingredients enjoyed the lower classification for decades.
The DEA changed that with a final rule effective October 6, 2014, moving all hydrocodone combination products up to Schedule II. This meant prescriptions could no longer be called in to a pharmacy, refills required a new written prescription, and there were tighter limits on supply. The reclassification reflected growing recognition of hydrocodone’s abuse potential. Notably, the Department of Health and Human Services had recommended in 2008 that the products stay in Schedule III, but the DEA ultimately overruled that recommendation after reviewing additional data on misuse patterns.
Side Effects Most People Experience
Opioid side effects are not rare occurrences. Roughly 73% of patients taking hydrocodone for non-cancer pain report side effects, and research has found that side effects, more than pain relief itself, explain most of the variation in how patients feel about taking the drug. The most commonly reported problems include dizziness, headache, fatigue, drowsiness, nausea, vomiting, and constipation. Constipation in particular tends to persist for as long as you take the medication, because unlike most other side effects, the body does not develop tolerance to it over time.
The most dangerous potential effect is respiratory depression, where breathing slows to a life-threatening degree. This risk increases significantly when hydrocodone is combined with benzodiazepines (anti-anxiety medications like Xanax or Valium), alcohol, or other sedatives, because all of these substances suppress the same breathing centers in the brain. People with reduced kidney or liver function face a higher risk at lower doses, since their bodies clear the drug more slowly.
Tolerance, Dependence, and Addiction Risk
Taking any opioid repeatedly causes your body to adjust. Over time, the brain produces fewer of its own natural pain-relieving chemicals, so the same dose of hydrocodone stops working as well. This is tolerance, and it is a predictable biological response, not a sign of addiction by itself. But tolerance often drives people to take higher doses, which is one of the ways opioid use disorder begins.
Physical dependence can develop even with short-term use. Research has found that after just five days of opioid use, the likelihood of still taking the medication a year later increases measurably. Dependence means your body has adapted to the drug’s presence and will produce withdrawal symptoms (anxiety, muscle aches, sweating, insomnia) if you stop abruptly. Addiction goes further: it involves compulsive use despite harm, a loss of control over how much and how often you take the drug.
These three stages, tolerance, dependence, and addiction, exist on a continuum. Not everyone who develops tolerance becomes addicted, but the progression is common enough that hydrocodone prescriptions are now written for the shortest effective duration whenever possible.
Hydrocodone Compared to Other Opioids
Hydrocodone occupies a middle tier in the opioid family. It is stronger than codeine and tramadol but weaker than oxycodone, morphine at higher doses, and significantly weaker than fentanyl. Its 1:1 equivalence with oral morphine makes it a useful reference point: if a prescription converts to more than 50 morphine milligram equivalents per day, guidelines flag it as carrying substantially higher overdose risk.
Unlike codeine, which the FDA restricted from use in patients under 18 for cough suppression (a change mandated in January 2018), hydrocodone fell under the same age restriction at the same time. Both drugs are now limited to adults for cough and cold formulations.